Jim Cramer, the well-known stock market expert and host of CNBC’s “Mad Money,” recently shared his thoughts on Cardinal Health, Inc. (CAH) and its CEO, Michael Kaufmann. In an interview with TheStreet, Cramer had high praise for Kaufmann, calling him “terrific.”
Cramer highlighted Kaufmann’s leadership during the COVID-19 pandemic, noting that Cardinal Health has been able to meet the increased demand for medical supplies and equipment. He also commended Kaufmann for his focus on the company’s long-term growth and diversification, particularly in the pharmaceutical distribution and medical device sectors.
Investors may find Cramer’s endorsement of Cardinal Health and Kaufmann encouraging, especially in a time of economic uncertainty. With a market capitalization of over $14 billion and a steady dividend yield of 3.12%, Cardinal Health may be an appealing investment option for those looking for stability and potential growth.
While Cramer’s praise for Kaufmann and Cardinal Health may be reassuring, it’s always important for investors to do their own research and due diligence before making any investment decisions. It’s also worth noting that Cardinal Health has faced some challenges in recent years, including legal battles and a decline in its stock price.
In summary, Jim Cramer’s positive review of Cardinal Health and its CEO may be a promising sign for the company’s future. However, investors should still carefully consider all factors when evaluating this stock as a potential investment opportunity. As always, stay informed and make educated decisions when it comes to your portfolio.